Efficacy and safety of dupilumab for moderate-to-severe atopic dermatitis: A systematic review for the EAACI biologicals guidelines. (2021)

First Author: Agache I

Attributed to: Cutaneous Immunology funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/all.14510

PubMed Identifier: 32691892

Publication URI: http://europepmc.org/abstract/MED/32691892

Type: Journal Article/Review

Volume: 76

Parent Publication: Allergy

Issue: 1

ISSN: 0105-4538